Search Results - DeAngelo, Sam

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Does Neck Strength Predict Repetitive Head Impacts In Youth Football Athletes?: 1543

    Does Neck Strength Predict Repetitive Head Impacts In Youth Football Athletes?: 1543 by Culiver, Adam, Smith, Carly, DeAngelo, Sam, Tracy, Ryan, Shoaf, Nick, Le Flao, Enora, Onate, James, Saygin, Zeynep, Caccese, Jaclyn

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia by Stein, Eytan M., DiNardo, Courtney D., Pollyea, Daniel A., Fathi, Amir T., Roboz, Gail J., Altman, Jessica K., Stone, Richard M., DeAngelo, Daniel J., Levine, Ross L., Flinn, Ian W., Kantarjian, Hagop M., Collins, Robert, Patel, Manish R., Frankel, Arthur E., Stein, Anthony, Sekeres, Mikkael A., Swords, Ronan T., Medeiros, Bruno C., Willekens, Christophe, Vyas, Paresh, Tosolini, Alessandra, Xu, Qiang, Knight, Robert D., Yen, Katharine E., Agresta, Sam, de Botton, Stephane, Tallman, Martin S.

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    AG-221, an Oral, Selective, First-in-Class, Potent Inhibitor of the IDH2 Mutant Metabolic Enzyme, Induces Durable Remissions in a Phase I Study in Patients with IDH2 Mutation Positive Advanced Hematologic Malignancies

    AG-221, an Oral, Selective, First-in-Class, Potent Inhibitor of the IDH2 Mutant Metabolic Enzyme, Induces Durable Remissions in a Phase I Study in Patients with IDH2 Mutation Posit... by Stein, Eytan M., Altman, Jessica K, Collins, Robert, DeAngelo, Daniel J, Fathi, Amir T, Flinn, Ian, Frankel, Arthur, Levine, Ross L, Medeiros, Bruno C, Patel, Manish, Pollyea, Daniel A, Roboz, Gail J., Stone, Richard M, Swords, Ronan T, Tallman, Martin S., Agresta, Sam, Fan, Bin, Yang, Hua, Yen, Katharine, de Botton, Stéphane

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience

    Phase II Trial of the mTOR Inhibitor RAD001 in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: The Dana Farber Cancer Institute Experience by Ghobrial, Irene M., Chuma, Stacey, Sam, Amy, Leduc, Renee, Nelson, Marybeth, O'Connor, Kelly, Harris, Brianna, Soumerai, Jacob, Warren, Diane, Jacobsen, Eric, DeAngelo, Daniel, Anderson, Kenneth C., Richardson, Paul G., Witzig, Thomas E., Treon, Steven P.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    A533 RAD001: Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia, the DFCI Experience

    A533 RAD001: Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia, the DFCI Experience by Ghobrial, IM, Roccaro, AM, Chuma, S, Sam, AP, Leduc, R, Nelson, M, O'Connor, K, Harris, B, Soumerai, J, Warren, D, Jacobsen, E, DeAngelo, D, Berg, W, Anderson, KC, Richardson, PG, Witzig, TE, Treon, SP

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: